1 study found for:    21631324 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma
Conditions: Recurrent Melanoma;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Biological: Aldesleukin;   Biological: gp100 Antigen;   Drug: Montanide ISA 51 VG;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis

Indicates status has not been verified in more than two years